secwatch.observer — SEC 8-K summary
======================================

Issuer:     Actinium Pharmaceuticals, Inc. (ATNM)
CIK:        0001388320
Form:       8-K
Filed at:   2023-12-01T23:59:59+00:00
Accession:  0001213900-23-092089
Event type: other
Sentiment:  neutral
Materiality: 0.20
Item codes: 5.02, 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Actinium shareholders re-elect Nicholson, Steinhart as Class I directors; Marcum LLP ratified as auditor
--------------------------------------------------------------------------------

- David Nicholson re-elected: 3,959,659 for, 3,275,844 withheld, 9,087,835 broker non-votes.
- Richard Steinhart re-elected: 5,630,379 for, 1,777,251 withheld, 9,087,835 broker non-votes.
- Marcum LLP ratified as independent auditor for FY2023: 15,842,146 for, 372,774 against, 280,545 abstain.
- No other matters voted on at the November 30, 2023 annual meeting.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1388320/000121390023092089/0001213900-23-092089-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1388320/000121390023092089/ea189365-8k_actinium.htm
  HTML page:      https://secwatch.observer/filing/0001213900-23-092089

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer